Company profile: InDevR
1.1 - Company Overview
Company description
- Provider of microarray technologies and novel solutions for the life science industry, including ampliPHOX Colorimetric Detection Technology for identification and differentiation of viruses such as Crimean-Congo hemorrhagic fever virus.
Products and services
- Microarray Technologies: Develops and fabricates microarray technologies for the life science industry, producing platforms and components tailored to microarray applications, industrial-grade
- AmpliPHOX Colorimetric Detection Technology: Constructs a detection system used for the identification and differentiation of viruses such as Crimean-Congo hemorrhagic fever virus, colorimetric
- Novel Solutions for the Life Science Industry: Offers novel products and systems to support the life science industry through innovative support offerings, custom-engineered
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InDevR
Arrevus
HQ: United States
Website
- Description: Provider of investigational therapies for Farber disease and serious infections. Based in Research Triangle Park, Arrevus develops ACG-801, an enzyme replacement therapy addressing acid ceramidase deficiency, and ACG-701, a novel oral antibiotic for melioidosis caused by B. pseudomallei with a unique dosing regimen and for acute cystic fibrosis-related pulmonary exacerbations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrevus company profile →
RQx Pharmaceuticals
HQ: United States
Website
- Description: Provider of broad spectrum antibiotic development; a biopharmaceutical company founded in 2010 and based in La Jolla, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RQx Pharmaceuticals company profile →
AIM ImmunoTech
HQ: United States
Website
- Description: Provider of immuno-pharmaceutical therapeutics centered on Ampligen, an immuno-modulator evaluated for cancer, immunodeficiency disorders and viral diseases, and approved in Argentina for severe chronic fatigue syndrome. Operates an Early Access Program in the Netherlands for pancreatic cancer, runs Phase 2 and combinational therapy trials in solid tumors, and studies ME/CFS and post-COVID conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AIM ImmunoTech company profile →
BioHelix
HQ: United States
Website
- Description: Provider of simple molecular diagnostic tests for the near patient setting, developed to improve the quality of healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioHelix company profile →
Xagenic
HQ: Canada
Website
- Description: Provider of on-demand molecular testing solutions that facilitate faster treatment decisions for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xagenic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InDevR
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InDevR
2.2 - Growth funds investing in similar companies to InDevR
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InDevR
4.2 - Public trading comparable groups for InDevR
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →